GBT - About the company
GBT is an acquired company based in San Francisco (United States), founded in 2011. It operates as a Developer of small molecules for the treatment of sickle cell disease. GBT has raised $88.7M in funding from investors like RA Capital Management, Deerfield and Wellington. The company has 28 active competitors, including 5 funded and 12 that have exited. Its top competitors include companies like Emmaus Medical, LogicBio and Kedrion.
Company Details
Developer of small molecules for the treatment of sickle cell disease. The company lead candidate, voxelotor (GBT440) is in Phase 3 trials and being investigated for the treatment of sickle cell disease. The candidate is a hemoglobin S polymerization inhibitor and its mechanism of action is modulation of hemoglobin affinity for oxygen.
- Website
- gbt.com
- Social
- Email ID
- *****@gbt.com
- Phone Number
- +1 **********
- Registered Address
- San Francisco (United States)
Key Metrics
Founded Year
2011
Location
San Francisco, United States
Stage
Acquired
Total Funding
$88.7M in 2 rounds
Latest Funding Round
Investors
Ranked
1st among 28 active competitors
Employee Count
74 as on May 31, 2026
Similar Companies
Exit Details
Acquired by Pfizer (Aug 08, 2022)
Legal entities associated with GBT
GBT is associated with 1 legal entity given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Documents |
|---|---|---|---|---|
Global Blood Therapeutics, Inc. CIN: 274825712 , Belgium, Active | Dec 31, 2010 | - | 457 (As on Dec 31, 2021) | - |
GBT's acquisition details
Click here to take a look at GBT's acquisition in detail
Sign up to download GBT's company profile
GBT's funding and investors
GBT has raised a total funding of $88.7M over 2 rounds. Its first funding round was on Jun 14, 2012. Its latest funding round was a Series B round on Jan 05, 2015 for $*****. 4 investors participated in its latest round. GBT has 10 institutional investors.
Here is the list of recent funding rounds of GBT:
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Jan 05, 2015 | 8267804 | Series B | 2410734 | 9753108 | 3005806 | 9628488 |
Jun 14, 2012 | 9863068 | Series A | 9106253 | 4589105 | 1049092 |
Access funding benchmarks and valuations. Sign up today!View details of GBT's funding rounds and investors
GBT's founders and board of directors
Founder? Claim ProfileGBT's employee count trend
GBT has 74 employees as of May 26. Here is GBT's employee count trend over the years:
Uncover GBT's growth story! Sign up today!
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
GBT's Competitors and alternates
Top competitors of GBT include Emmaus Medical, LogicBio and Kedrion. Here is the list of Top 10 competitors of GBT, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | GBT 2011, San Francisco (United States), Acquired | Developer of small molecules for the treatment of sickle cell disease | $88.7M | 58/100 | |
2nd | Emmaus Medical 2000, Torrance (United States), Acquired | Developer of small molecule therapeutics for the treatment of sickle cell anemia and sickle ß0-thalassemia | - | 61/100 | |
3rd |  LogicBio 2013, Lexington (United States), Acquired | Developer of viral vectors for the treatment of genetic and infectious diseases | $49M | 60/100 | |
4th | Developer of plasma-derived products for hemophilia and immune system deficiencies | $189M | 59/100 | ||
5th |  Imara 2016, Cambridge (United States), Public | Small molecules to treat rare blood diseases such as sickle cell disease | $94M | 57/100 | |
6th |  Cyclerion 2018, Cambridge (United States), Public | Developer of therapies for treating sickle cell disease and diabetic nephropathy | - | 55/100 | |
7th | _1591332761406.jpg?devicePixelRatio=2&height=30&width=30){kind=logo} Editas Medicine 2013, Cambridge (United States), Public | Developer of therapeutics for rare genetic diseases | $210M | 54/100 | |
8th | Sierra Oncology 2003, Vancouver (Canada), Acquired | Developer of targeted therapies to treat cancer | $75M | 54/100 | |
9th | Octapharma 1983, Lachen (Switzerland), Unfunded | Developer of plasma derived therapeutics for multiple diseases | - | - | 53/100 |
10th | Modus Therapeutics 2011, Stockholm (Sweden), Series B | Developers of polysaccharide based drug for the treatment of Sickle Cell Disease | $22.9M | 53/100 |
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on GBT's competitors? Click here to see the top ones
GBT's Investments and acquisitions
GBT has made no investments or acquisitions yet.
News related to GBT
Filter this list•
•
•
Structure Therapeutics Appoints Ted W. Love, M.D., to Board of DirectorsGlobeNewswire•Aug 04, 2023•Structure, GBT
•
Pfizer acquires Global Blood Therapeutics for $5.4bnPharmaceutical Technology•Oct 06, 2022•Pfizer, GBT
•
BioPharma Credit receives USD175 million from Pfizer dealMorningstar•Oct 06, 2022•bpcruk, Pharmakon Advisors, GBT
•
Global Blood Therapeutics expects to complete Pfizer deal in early OctoberSeeking Alpha•Oct 01, 2022•GBT, Pfizer
•
The M&A Class Action Firm Launches Merger Inquiry - RFP, SBTX, GBT, EVOPPR Newswire•Sep 24, 2022•Monteverde, Resolute Forest Products, Silverback Therapeutics, GBT and 1 other
•
The M&A Class Action Firm Continues Investigating the Merger – RFP, SBTX, GBT, EVOPGlobeNewswire•Sep 21, 2022•Monteverde, Resolute Forest Products, GBT, EVO Payments
•
•
Pfizer said to have had bidding war with Johnson & Johnson for Global BloodSeeking Alpha•Aug 24, 2022•Pfizer, Johnson & Johnson, GBT
Get curated news about company updates, funding rounds, M&A deals and others. Sign up today!Are you a Founder ?
FAQs about GBT
Explore our recently published companies
- DRPU Software - Ghaziabad based, 2008 founded, Public company
- Independent School District 625 - United States based, Funding Raised company
- Scioto Valley Solar One - Funding Raised company
- Beacon Display - Sutton Coldfield based, 1976 founded, Unfunded company
- Lonsen Kiri Chemical Industries - Vadodara based, 2008 founded, Unfunded company
- Pltindustries - Delhi based, 1995 founded, Unfunded company
